Anti-viral Action Against Type 1 Diabetes Autoimmunity
Conditions
Diabetes Mellitus, Type 1
Simple summaryAI-assisted
This summary is produced by a language model and is experimental. It may be incomplete or inaccurate and is not a substitute for professional medical advice.
Locations
Medical University of Vienna, Dept. of Pediatric and Adolescent Medicine, Waehringer Gürtel 18-20, 1090 Vienna, Austria, Vienna, Austria
Contact: Study coordinator (Birgit Rami-Merhar, Prof.) · Birgit.Rami@meduniwien.ac.at · +43-1-40400-32320University Hospitals Leuven, Faculty of Medicine, Catholic University of Leuven, Leuven, Belgium
Contact: Study coordinator (Kristina Casteels, Prof. Dr.)Klinikum rechts der Isar of Technical University Munich and Institute for Diabetes Research, Helmholtz Munich, Munich, Bavaria, Germany
Contact: Study coordinator (Anette-G Ziegler, Prof. Dr.) · anettegabriele.ziegler@helmholtz-munich.de · +49-89-3187AUF DER BULT, Kinder- und Jugendkrankenhaus, Hanover, Lower Saxony, Germany
Contact: Study coordinator (Olga Kordonouri, Prof. Dr.)Klinik und Poliklinik f. Kinder und Jugendmedizin, Universitätsklinikum Carl Gustav Carus, Technische Universität Dresden, Dresden, Saxony, Germany
Contact: Study coordinator (Reinhard Berner, Prof.Dr.)Lund University Dep. of Clinical Sciences Malmo, Skane University Hospital SUS, Malmö, Sweden
Contact: Study coordinator (Marcus Lundgren, Dr.)Birmingham Women's and Children's NHS Foundation Trust, Birmingham, United Kingdom
Contact: Study coordinator (Renuka Dias)Cambridge University Hospitals NHS Foundation Trust, Cambridge, United Kingdom
Contact: Study coordinator (Loredana Marcovecchio, MD, PhD)The Newcastle upon Tyne Hospitals NHS Foundation Trust, Newcastle, United Kingdom
Contact: Study coordinator (Catherine Owen, PhD)
Study leads
Anette-G. Ziegler
Principal Investigator
Klinikum r.d.Isar of Technical University Munich and Institute for Diabetes Research, Helmholtz Munich, Heidemannstr.1, 80939 Munich, Germany